FDA Grants 'Breakthrough Therapy' Status To Potential Autism Drug

MLA

Diament, Michelle. “FDA Grants ‘Breakthrough Therapy’ Status To Potential Autism Drug.” Palaestra, vol. 32, no. 2, Mar. 2018, p. 58. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.559357079&authtype=sso&custid=ns315887.

APA

Diament, M. (2018). FDA Grants “Breakthrough Therapy” Status To Potential Autism Drug. Palaestra, 32(2), 58.

Chicago

Diament, Michelle. 2018. “FDA Grants ‘Breakthrough Therapy’ Status To Potential Autism Drug.” Palaestra 32 (2): 58. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.559357079&authtype=sso&custid=ns315887.